Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
8.49
+0.27 (3.28%)
At close: Jul 21, 2026, 4:00 PM EDT
8.49
0.00 (0.00%)
After-hours: Jul 21, 2026, 4:01 PM EDT
Anteris Technologies Global Employees
Anteris Technologies Global had 174 employees as of December 31, 2025. The number of employees increased by 38 or 27.94% compared to the previous year.
Employees
174
Change (1Y)
38
Growth (1Y)
27.94%
Revenue / Employee
$10,638
Profits / Employee
-$547,724
Market Cap
827.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 174 | 38 | 27.94% |
| Dec 31, 2024 | 136 | 15 | 12.40% |
| Sep 30, 2024 | 138 | - | - |
| Mar 31, 2024 | 121 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Azenta | 2,900 |
| AtriCure | 1,350 |
| STAAR Surgical Company | 921 |
| LeMaitre Vascular | 655 |
| AngioDynamics | 632 |
| OraSure Technologies | 500 |
| Kestra Medical Technologies | 330 |
| Alamar Biosciences | 222 |
AVR News
- 19 days ago - Anteris Technologies files to sell 5.39M shares of common stock - TheFly
- 6 weeks ago - Anteris Technologies cleared by ANSM for DurAVR THV trial - TheFly
- 6 weeks ago - Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance - GlobeNewsWire
- 2 months ago - Anteris Technologies price target raised to $18 from $17 at Barclays - TheFly
- 2 months ago - Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors - GlobeNewsWire
- 2 months ago - Anteris Announces Results for the First Quarter of 2026 - GlobeNewsWire
- 2 months ago - Anteris Technologies: First U.S. patients treated in global PARADIGM trial - TheFly
- 2 months ago - Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial - GlobeNewsWire